This article is a correction to:
The predictive validity of a Brain Care Score for late-life depression and a composite outcome of dementia, stroke, and late-life depression: data from the UK Biobank cohort
Sanjula D. Singh1,2,3‡
Cyprien A. Rivier4,5‡
Keren Papier6†
Zeina Chemali1,2,7
Leidys Gutierrez-Martinez1,2,3Livia Parodi1,2,3,8,9
Ernst Mayerhofer1,2,3,8,9
Jasper Senff1,2,3,10
Santiago Clocchiatti-Tuozzo4,5Courtney Nunley1
Amy Newhouse1,7,11
An Ouyang1
M. Brandon Westover1,2
Rudolph E. Tanzi1,2
Ronald M. Lazar12
Aleksandra Pikula13,14
Sarah Ibrahim13,15,16,17H. Bart Brouwers18
Virginia J. Howard19
George Howard19Nirupama Yechoor1,2,3Thomas Littlejohns6Kevin N. Sheth4,5
Jonathan Rosand1,2,3,8Gregory Fricchione1,20
Christopher D. Anderson1,2,3,8,9*‡
Guido J. Falcone4,5*‡- 1Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, United States
- 2Department of Neurology, Massachusetts General Hospital, Boston, MA, United States
- 3Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States
- 4Department of Neurology, Yale School of Medicine, New Haven, CT, United States
- 5Yale Center for Brain and Mind Health, New Haven, CT, United States
- 6Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom
- 7Division of Neuropsychiatry, Massachusetts General Hospital, Boston, MA, United States
- 8Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, United States
- 9Department of Neurology, Brigham and Women’s Hospitall, Boston, MA, United States
- 10Department of Neurology, Rudolf Magnus Institute of Neuroscience, University Medical Centre Utrecht, Utrecht, Netherlands
- 11Department of Medicine, Massachusetts General Hospital, Boston, MA, United States
- 12Department of Neurology, University of Alabama at Birmingham (UAB) Heersink School of Medicine, University of Alabama at Birmingham (UAB) McKnight Brain Institute, Birmingham, AL, United States
- 13Jay and Sari Sonshine Centre for Stroke Prevention & Cerebrovascular Brain Health, University Health Network, Krembil Brain Institute, Toronto, ON, Canada
- 14Department of Medicine, Division of Neurology, The Temerty Faculty of Medicine at the University of Toronto, Toronto, ON, Canada
- 15Program for Health System and Technology Evaluation; Toronto General Hospital Research Institute, Toronto, ON, Canada
- 16Institute of Health Policy, Management and Evaluation (IHPME), Dalla Lana School of Public Health; University of Toronto, Toronto, ON, Canada
- 17Centre for Advancing Collaborative Healthcare & Education (CACHE), University of Toronto, Toronto, ON, Canada
- 18Department of Neurosurgery, Elisabeth TweeSteden Ziekenhuis, Tilburg, Netherlands
- 19Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, United States
- 20Benson-Henry Institute for Mind Body Medicine, Massachusetts General Hospital, Boston, MA, United States
By Singh SD, Rivier CA, Papier K, Chemali Z, Gutierrez-Martinez L, Parodi L, Mayerhofer E, Senff J, Clocchiatti-Tuozzo S, Nunley C, Newhouse A, Ouyang A, Westover MB, Tanzi RE, Lazar RM, Pikula A, Ibrahim S, Brouwers HB, Howard VJ, Howard G, Yechoor N, Littlejohns T, Sheth KN, Rosand J, Fricchione G, Anderson CD and Falcone GJ (2024) Front. Psychiatry 15:1373797. doi: 10.3389/fpsyt.2024.1373797
In the published article there was a error in the Conflict of interest statement for M. Brandon Westover. The statement was previously:
“CA receives sponsored research support from the US National Institutes of Health, the American Heart Association, and Bayer AG, and has consulted for ApoPharma. GF receives sponsored research support from the National Institute of Mental Health Clinical Global Mental Health Research T32 Fellowship, receives royalties or licenses from Johns Hopkins University Press, University of Chicago Press, Belvoir Press, and the American Psychiatric Press, is on a Data Safety Monitoring Board or Advisory Board of Healthy Hearts Healthy Minds DSMB, is a Board of Directors member at the Rosalynn Carter Institute, and has stock or stock options from Revival Therapeutics Consultant. LG-M receives sponsored research support from the American Heart grant number 963719. JR receives sponsored research support from the US National Institutes of Health and the American Heart Association, and receives payments for expert testimony and consulting fees from the National Football League. EM is an employee of Regeneron Genetics Center.
The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.”
The correct statement appears below:
“CA receives sponsored research support from the US National Institutes of Health, the American Heart Association, and Bayer AG, and has consulted for ApoPharma. GF receives sponsored research support from the National Institute of Mental Health Clinical Global Mental Health Research T32 Fellowship, receives royalties or licenses from Johns Hopkins University Press, University of Chicago Press, Belvoir Press, and the American Psychiatric Press, is on a Data Safety Monitoring Board or Advisory Board of Healthy Hearts Healthy Minds DSMB, is a Board of Directors member at the Rosalynn Carter Institute, and has stock or stock options from Revival Therapeutics Consultant. LG-M receives sponsored research support from the American Heart grant number 963719. JR receives sponsored research support from the US National Institutes of Health and the American Heart Association, and receives payments for expert testimony and consulting fees from the National Football League. EM is an employee of Regeneron Genetics Center. MW has private equity as co-founder of Beacon Biosignals and receives compensation for consulting and scientific advisory roles.
The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: depression - epidemiology, prevention, risk factor, brain health, stroke, dementia
Citation: Singh SD, Rivier CA, Papier K, Chemali Z, Gutierrez-Martinez L, Parodi L, Mayerhofer E, Senff J, Clocchiatti-Tuozzo S, Nunley C, Newhouse A, Ouyang A, Westover MB, Tanzi RE, Lazar RM, Pikula A, Ibrahim S, Brouwers HB, Howard VJ, Howard G, Yechoor N, Littlejohns T, Sheth KN, Rosand J, Fricchione G, Anderson CD and Falcone GJ (2024) Corrigendum: The predictive validity of a Brain Care Score for late-life depression and a composite outcome of dementia, stroke, and late-life depression: data from the UK Biobank cohort. Front. Psychiatry 15:1502482. doi: 10.3389/fpsyt.2024.1502482
Received: 25 October 2024; Accepted: 30 October 2024;
Published: 12 November 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Singh, Rivier, Papier, Chemali, Gutierrez-Martinez, Parodi, Mayerhofer, Senff, Clocchiatti-Tuozzo, Nunley, Newhouse, Ouyang, Westover, Tanzi, Lazar, Pikula, Ibrahim, Brouwers, Howard, Howard, Yechoor, Littlejohns, Sheth, Rosand, Fricchione, Anderson and Falcone. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Christopher D. Anderson, cdanderson@mgb.org; Guido J. Falcone, guido.falcone@yale.edu
†Present address: Keren Papier, Cancer Epidemiology Unit, Nuffield Department of Population Health, Oxford, United Kingdom
‡These authors have contributed equally to this work